European Multicentre Trial Group: Cyclosporin in cadaveric renal transplantation: one year follow-up of a multicentre trial.Lancet, oct. 29; 986–989 (1983).
5.
GoreyT., SpeesE. K., SapirD., MostofiF. K.: Renal malipnancies are increased in transplantation candidates. J. Urol., 131; 230 (1984).
6.
HerrH. W., EngenD. E., HostetlerJ.: Malignancy in uremia: dialysis versus transplantation. J. Urol., 121; 584–586 (1979).
7.
PennI., StarzlT. E.: Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation, 14; 407–417 (1972).
8.
PennI.: Tumor incidence in human allograft recipients. Transplant. Proc., 9; 1047–1051 (1979).
9.
PennI.: Development of cancer as a complication of clinical transplantation, Transplant. Proc., 9; 1121–1127 (1977).
10.
RoccaRossetti S., MutoG.: Possibilità e limiti della terapia conservativa del carcinoma renale. In: VeronesiU., LasioE., EmanuelliH., PizzocaroG., De LenaM.: I tumori urologici, p. 47–54, Casa Editrice Ambrosiana, Milano1982.
11.
SheilA. G. R., MayJ., MahoneyJ. F., HorvathJ. S., JohnsonJ. R., TillerD. T., StewartT. H.: Incidence of cancer in renal transplant recipient. Proc. EDTA, 17; 502–511 (1980).
12.
TurnerB. J., RichieR. E., JohnsonH. K., McDonellR. C.Jr., TallentM. B., NiblackG. D.: Bilateral nephrectomy concomitantly with renal transplantation. J. Urol., 130; 240–242 (1983).
